Prognostic Value of Coronary Angiography-Derived Index of Microcirculatory Resistance in Patients With Intermediate Coronary Stenosis

Yiyue Zheng, Yuxuan Zhang, Delong Chen, Abuduwufuer Yidilisi, Jiacheng Fang, Xinyi Zhang, Jicaidan Dao, Xinyang Hu, Jinlong Zhang, Die Hu, Airong Fu, Shiqiang Li, Seokhun Yang, Jeehoon Kang, Doyeon Hwang, Joo Yong Hahn, Chang Wook Nam, Joon Hyung Doh, Bong Ki Lee, Weon KimJinyu Huang, Fan Jiang, Hao Zhou, Peng Chen, Lijiang Tang, Wenbing Jiang, Xiaomin Chen, Wenming He, Sung Gyun Ahn, Myeong Ho Yoon, Ung Kim, Joo Myung Lee, You Jeong Ki, Eun Seok Shin, Chee Hae Kim, Jianping Xiang, Seung Jea Tahk, Bon Kwon Koo, Jian'an Wang, Jun Jiang

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Abstract

Background: The association between coronary microcirculation and clinical outcomes in patients with intermediate stenosis remains unclear. Objectives: The aim of this study was to assess the prognostic significance of angiography-derived index of microcirculatory resistance (angio-IMR) in patients with intermediate coronary stenosis. Methods: This post hoc analysis included 1,658 patients from the FLAVOUR (Fractional Flow Reserve and Intravascular Ultrasound for Clinical Outcomes in Patients with Intermediate Stenosis) trial, with angio-IMR measured in each vessel exhibiting intermediate stenosis. The primary endpoint was a patient-oriented composite outcome (POCO), a composite of all-cause death, myocardial infarction, or revascularization over a 2-year period. Results: The median follow-up period was 24.8 months (Q1-Q3: 24.4-26.4 months). Over the 2-year follow-up period, patients with angio-IMR >25 exhibited a significantly higher POCO rate in both the percutaneous coronary intervention (PCI) group (35.06% [27 of 77] vs 7.2% [51 of 708]; P < 0.001) and the non-PCI group (17.95% [21 of 117] vs 4.23% [32 of 756]; P < 0.001). After adjusting for potentially related risk factors, angio-IMR >25 remained an independent predictor of the POCO in the PCI group (HR: 6.235; 95% CI: 3.811-10.203; P < 0.001) and the non-PCI group (HR: 5.282; 95% CI: 2.948-9.462; P < 0.001). The addition of angio-IMR demonstrated incremental prognostic value in both an angiographic risk factor model (C-index 0.710 [95% CI: 0.663-0.756] vs 0.615 [95% CI: 0.563-0.664] [P < 0.001]; net reclassification index 0.268 [95% CI: 0.191-0.362; P < 0.001]; integrated discrimination improvement 0.055 [95% CI: 0.030-0.108; P < 0.001]) and a clinical risk factor model (C-index 0.705 [95% CI: 0.658-0.751] vs 0.594 [95% CI: 0.544-0.644] [P < 0.001]; net reclassification index 0.268 [95% CI: 0.171-0.350; P < 0.001]; integrated discrimination improvement 0.057 [95% CI: 0.027-0.102; P < 0.001]). Conclusions: In individuals with intermediate coronary stenosis, elevated angio-IMR is linked to an adverse prognosis. Using angio-IMR significantly enhanced the capability to reclassify patients and accurately estimate the risk for the POCO.

Original languageEnglish
Pages (from-to)171-183
Number of pages13
JournalJACC: Cardiovascular Interventions
Volume18
Issue number2
DOIs
Publication statusPublished - 27 Jan 2025

Bibliographical note

Publisher Copyright:
© 2025 The Authors

Keywords

  • coronary angiography
  • index of microcirculatory resistance
  • intermediate coronary stenosis
  • microcirculation
  • prognosis

Fingerprint

Dive into the research topics of 'Prognostic Value of Coronary Angiography-Derived Index of Microcirculatory Resistance in Patients With Intermediate Coronary Stenosis'. Together they form a unique fingerprint.

Cite this